Literature DB >> 16107013

[Origin and distribution of brain metastases].

Nemanja Popović1, Dario Kalacun.   

Abstract

INTRODUCTION: Malignant neoplasmas account for 20% of overall mortality in developed countries, and are the second leading cause of death. According to the World Health Organization central nervous system tumors account for 4% of all tumors and brain tumors cause 0.2-2.4% of all hospital deaths. By their origin, brain tumors are classified into primary and secondary tumors or metastases. The aims of this study were to examine the number of metastases, their origin and distribution and to compare the prevalence of primary and secondary brain tumors during the same period.
MATERIAL AND METHODS: A retrospective cohort study included 63 adults (40 males and 23 females) with diagnosed brain tumors treated during 2001 and 2002 at the Department of Neurology in Novi Sad. Tumors were diagnosed by computed tomography and magnetic resonance imaging.
RESULTS: Secondary tumors were also diagnosed, but without statistical significance (2 = 0.38; p > 0.05) and metastases were significantly more frequent among men (2 = 14.22; p < 0.01). Supratentorial metastases were significantly more frequent than tumors in other localizations (2 = 23.6; p < 0.01). Multiple metastases were estimated in 56% of patients and solitary tumors in 44%, without statistical significance (2 = 0.48; p > 0.05). In most cases metastases originated from primary lung cancers and tumors of unknown origin.
CONCLUSIONS: During the studied period more secondary than primary tumors have been diagnosed and more multiple than solitary metastases. They were more frequent in men with supratentorial distribution as most frequent. Lung cancer proved to be their most common source.

Entities:  

Mesh:

Year:  2004        PMID: 16107013     DOI: 10.2298/mpns0412617p

Source DB:  PubMed          Journal:  Med Pregl        ISSN: 0025-8105


  2 in total

1.  A case of primary lung cancer lesion demonstrated by F-18 FDG positron emission tomography/computed tomography (PET/CT) one year after the detection of metastatic brain tumor.

Authors:  Yuichi Ozeki; Yoshiyuki Abe; Hideyuki Kita; Katsumi Tamura; Ikuko Sakata; Jiro Ishida; Kikuo Machida
Journal:  Oncol Lett       Date:  2011-05-16       Impact factor: 2.967

2.  Detection of unknown primary tumor in patients presented with brain metastasis by F-18 fluorodeoxyglucose positron emission tomography/computed tomography.

Authors:  Zehra Pınar Koç; Pelin Özcan Kara; Ahmet Dağtekin
Journal:  CNS Oncol       Date:  2018-04-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.